MetaADEDB 2.0 @ LMMD
Cloxacillin
(LQOLIRLGBULYKD-JKIFEVAISA-N)
Structure
SMILES
OC(=O)[C@@H]1N2C(=O)[C@H]([C@H]2SC1(C)C)NC(=O)c1c(C)onc1c1ccccc1Cl
Type(s)
Approved; Investigational; Vet_approved
ATC code(s)
J01CF02; J01CR50
Molecular Formula:
C19H18ClN3O5S
Molecular Weight:
435.881
Log P:
2.8775
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
2
TPSA:
138.04
CAS Number(s):
61-72-3
Synonym(s)
1.
Cloxacillin
2.
Chloroxacillin
3.
Sodium Cloxacillin
4.
Cloxacillin Sodium
5.
Syntarpen
6.
Tegopen
7.
Cloxacillin, Sodium
8.
Sodium, Cloxacillin
External Link(s)
MeSHD003023
PubChem Compound6098
BindingDB50022788
ChEBI49566
CHEMBLCHEMBL891
DrugBankDB01147
DrugCentral720
KEGGcpd:C06923
dr:D07733
Therapeutic Target DatabaseD04KTZ
ZINC3875417
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainCanada Vigilance: 211476450CTD
Canada Vigilance
2Abdominal discomfortCanada Vigilance: 2Canada Vigilance
3Acute Coronary SyndromeOFFSIDES
4Alanine Aminotransferase IncreasedOFFSIDES
5Amylase increasedCanada Vigilance: 1Canada Vigilance
6Anaphylactoid ReactionCanada Vigilance: 3Canada Vigilance
7Anemia, Hemolytic4124995CTD
8AngioedemaCanada Vigilance: 116540070CTD
Canada Vigilance
9AnorexiaOFFSIDES
10Arteritis obliteransOFFSIDES
11Arthralgia1305739
11476450
CTD
12ArthritisCanada Vigilance: 1Canada Vigilance
13ArthropathyOFFSIDES
14Ascites11476450CTD
15AstheniaCanada Vigilance: 4Canada Vigilance
16Atrioventricular BlockOFFSIDES
17Back Pain1421648CTD
18Biopsy bone marrow abnormalOFFSIDES
19Blood creatinine increasedCanada Vigilance: 2Canada Vigilance
OFFSIDES
20Blood triglycerides increasedOFFSIDES
21Blood urea increasedCanada Vigilance: 2Canada Vigilance
22Bronchial ObstructionOFFSIDES
23BronchopneumoniaOFFSIDES
24Cellulitis16540070CTD
25Chemical and Drug Induced Liver Injury9538497
11476450
24085192
CTD
26Chest PainCanada Vigilance: 1Canada Vigilance
27Choking sensationOFFSIDES
28CholangiolitisOFFSIDES
29Cholestasis

View details

CTD
30Cholestatic liver injuryOFFSIDES
31ChromaturiaCanada Vigilance: 1Canada Vigilance
OFFSIDES
32CirrhosisOFFSIDES
33Clostridium difficile infectionCanada Vigilance: 1Canada Vigilance
34Coagulation factor increasedOFFSIDES
35Complication associated with deviceCanada Vigilance: 1Canada Vigilance
36Confusion6867701CTD
37Cytolytic hepatitisOFFSIDES
38DehydrationCanada Vigilance: 1Canada Vigilance
39DermatitisCanada Vigilance: 1Canada Vigilance
40Device occlusionCanada Vigilance: 1Canada Vigilance
41Diarrhea11476450CTD
42DizzinessCanada Vigilance: 3Canada Vigilance
43Drug Eruptions16540070CTD
44Drug ineffectiveOFFSIDES
45DyspepsiaCanada Vigilance: 3Canada Vigilance
46Dyspnea11476450CTD
47EczemaCanada Vigilance: 1Canada Vigilance
48Edema1421648CTD
49Ejection fraction abnormalOFFSIDES
50EndocarditisOFFSIDES
51EosinophiliaCanada Vigilance: 27284928
11476450
CTD
Canada Vigilance
52Epilepsy8487076CTD
53Erythema MultiformeCanada Vigilance: 1Canada Vigilance
54ErythemaCanada Vigilance: 9Canada Vigilance
OFFSIDES
55Exanthema11476450CTD
56FatigueCanada Vigilance: 1Canada Vigilance
57Fever11476450CTD
58FlushingCanada Vigilance: 3Canada Vigilance
59GastritisCanada Vigilance: 2Canada Vigilance
60GastroenteritisCanada Vigilance: 1Canada Vigilance
OFFSIDES
61Gastrointestinal PainCanada Vigilance: 1Canada Vigilance
62Gastrointestinal infectionCanada Vigilance: 1Canada Vigilance
63GlobulinuriaOFFSIDES
64HeadacheCanada Vigilance: 2Canada Vigilance
65Hematuria7284928CTD
66Hepatic necrosisOFFSIDES
67Hepatomegaly11476450CTD
68HypercreatininaemiaOFFSIDES
69HyperpigmentationOFFSIDES
70HypersensitivityCanada Vigilance: 3Canada Vigilance
71Hypokalemia9547205CTD
72HypokinesiaOFFSIDES
73InfectionOFFSIDES
74Jaundice, Obstructive3776959
7417768
7893901
CTD
75Leukocytosis11476450CTD
76LeukopeniaCanada Vigilance: 17284928CTD
Canada Vigilance
77Lip swellingCanada Vigilance: 1Canada Vigilance
78Lipase increasedCanada Vigilance: 1Canada Vigilance
79Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
80MalaiseCanada Vigilance: 1Canada Vigilance
81Mastication disorderOFFSIDES
82Medication ErrorCanada Vigilance: 1Canada Vigilance
83Mucocutaneous candidiasisOFFSIDES
84Muscle necrosisOFFSIDES
85MydriasisCanada Vigilance: 1Canada Vigilance
86NauseaCanada Vigilance: 131305739CTD
Canada Vigilance
87Nephritis, Interstitial

View details

CTD
88NervousnessCanada Vigilance: 1Canada Vigilance
89NeutropeniaCanada Vigilance: 47284928CTD
Canada Vigilance
90Nipple painCanada Vigilance: 1Canada Vigilance
91PallorCanada Vigilance: 1Canada Vigilance
92PancreatitisCanada Vigilance: 1Canada Vigilance
OFFSIDES
93PetechiaeCanada Vigilance: 1Canada Vigilance
94Pharyngeal swellingCanada Vigilance: 2Canada Vigilance
95PhlebitisCanada Vigilance: 17447412
12953952
CTD
Canada Vigilance
96Popliteal pulse decreasedOFFSIDES
97Portal HypertensionOFFSIDES
98Post procedural complicationOFFSIDES
99Product depositCanada Vigilance: 2Canada Vigilance
100PruritusCanada Vigilance: 97893901CTD
Canada Vigilance
101PsoriasisOFFSIDES
102Pulmonary HypertensionOFFSIDES
103PurpuraCanada Vigilance: 1Canada Vigilance
104Pyogenic granulomaOFFSIDES
105Pyuria1421648CTD
106Rash erythematousCanada Vigilance: 7Canada Vigilance
107Renal Insufficiency1421648CTD
108RetchingCanada Vigilance: 1Canada Vigilance
109Shoulder PainOFFSIDES
110Skin lesionOFFSIDES
111Staphylococcal Infections

View details

CTD
112Stevens-Johnson SyndromeCanada Vigilance: 1Canada Vigilance
113StomatitisCanada Vigilance: 1Canada Vigilance
114StridorOFFSIDES
115Sudden deathOFFSIDES
116Suppressed lactationCanada Vigilance: 1Canada Vigilance
117TachycardiaCanada Vigilance: 1Canada Vigilance
118Therapeutic product ineffectiveOFFSIDES
119Urethral StenosisOFFSIDES
120UrticariaCanada Vigilance: 14Canada Vigilance
121Varicose Ulcer7249889CTD
122VasculitisCanada Vigilance: 1Canada Vigilance
123Visual ImpairmentCanada Vigilance: 1Canada Vigilance
124Vitamin K DeficiencyOFFSIDES
125VomitingCanada Vigilance: 101305739CTD
Canada Vigilance
126Weight decreasedCanada Vigilance: 1Canada Vigilance
127jaundiceCanada Vigilance: 211476450CTD
Canada Vigilance
128pseudomembranous colitisCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.